Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Medical guidelines

Vol. 154 No. 2 (2024)

Palliative sedation – revised recommendations

  • Michel Beauverd
  • Marta Mazzoli
  • Josiane Pralong
  • Martyna Tomczyk
  • Steffen Eychmüller
  • Jan Gaertner
DOI
https://doi.org/10.57187/s.3590
Cite this as:
Swiss Med Wkly. 2024;154:3590
Published
15.02.2024

Summary

Palliative sedation is defined as the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) to relieve the burden of otherwise intractable suffering in a manner ethically acceptable to the patient, their family, and healthcare providers. In Switzerland, the prevalence of continuous deep sedation until death increased from 4.7% in 2001 to 17.5% of all deceased in 2013, depending on the research method used and on regional variations. Yet, these numbers may be overestimated due to a lack of understanding of the term “continuous deep sedation” by for example respondents of the questionnaire-based study.

Inadequately trained and inexperienced healthcare professionals may incorrectly or inappropriately perform palliative sedation due to uncertainties regarding its definitions and practice. Therefore, the expert members of the Bigorio group and the authors of this manuscript believe that national recommendations should be published and made available to healthcare professionals to provide practical, terminological, and ethical guidance. The Bigorio group is the working group of the Swiss Palliative Care Society whose task is to publish clinical recommendations at a national level in Switzerland. These recommendations aim to provide guidance on the most critical questions and issues related to palliative sedation.

The Swiss Society of Palliative Care (palliative.ch) mandated a writing board comprising four clinical experts (three physicians and one ethicist) and two national academic experts to revise the 2005 Bigorio guidelines. A first draft was created based on a narrative literature review, which was internally reviewed by five academic institutions (Lausanne, Geneva, Bern, Zürich, and Basel) and the heads of all working groups of the Swiss Society of Palliative Care before finalising the guidelines.

The following themes are discussed regarding palliative sedation: (a) definitions and clinical aspects, (b) the decision-making process, (c) communication with patients and families, (d) patient monitoring, (e) pharmacological approaches, and (f) ethical and controversial issues. Palliative sedation must be practised with clinical and ethical accuracy and competence to avoid harm and ethically questionable use. Specialist palliative care teams should be consulted before initiating palliative sedation to avoid overlooking other potential treatment options for the patient’s symptoms and suffering.

References

  1. Cherny NI, Radbruch L; Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009 Oct;23(7):581–93. 10.1177/0269216309107024 DOI: https://doi.org/10.1177/0269216309107024
  2. de Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med. 2007 Feb;10(1):67–85. 10.1089/jpm.2006.0139 DOI: https://doi.org/10.1089/jpm.2006.0139
  3. Tomczyk M, Viallard ML, Beloucif S. [Current status of clinical practice guidelines on palliative sedation for adults in French-speaking countries]. Bull Cancer. 2021 Mar;108(3):284–94. 10.1016/j.bulcan.2020.10.011 DOI: https://doi.org/10.1016/j.bulcan.2020.10.011
  4. Cherny NI; ESMO Guidelines Working Group. ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol. 2014 Sep;25 Suppl 3:iii143–52. 10.1093/annonc/mdu238 DOI: https://doi.org/10.1093/annonc/mdu238
  5. Handlungsempfhelung EINSATZ SEDIERENDER MEDIKAMENTE IN DER SPEZIALISIERTEN PALLIATIVVERSORGUNG. Forschungsverbund SedPall. DGP; 2021.
  6. Surges SM, Garralda E, Jaspers B, Brunsch H, Rijpstra M, Hasselaar J, et al. Review of European Guidelines on Palliative Sedation: A Foundation for the Updating of the European Association for Palliative Care Framework. J Palliat Med. 2022 Nov;25(11):1721–31. 10.1089/jpm.2021.0646 DOI: https://doi.org/10.1089/jpm.2021.0646
  7. Arantzamendi M, Belar A, Payne S, Rijpstra M, Preston N, Menten J, et al. Clinical Aspects of Palliative Sedation in Prospective Studies. A Systematic Review. J Pain Symptom Manage. 2021 Apr;61(4):831–844.e10. 10.1016/j.jpainsymman.2020.09.022 DOI: https://doi.org/10.1016/j.jpainsymman.2020.09.022
  8. Abarshi E, Rietjens J, Robijn L, Caraceni A, Payne S, Deliens L, et al.; EURO IMPACT. International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care. 2017 Sep;7(3):223–9. 10.1136/bmjspcare-2016-001159 DOI: https://doi.org/10.1136/bmjspcare-2016-001159
  9. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al.; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec;182(18):E839–42. 10.1503/cmaj.090449 DOI: https://doi.org/10.1503/cmaj.090449
  10. Japanese Society for Palliative Medicine. Guidelines for sedation for pain relief., in http://www.jspm.ne.jp/guidelines/sedation/sedation01.pdf. 2015.
  11. Committee on National Guideline for Palliative Sedation. Utrecht, Guideline for palliative sedation, in http://palliativedrugs.com/download/091110_KNMG_Guideline_for_Palliative_sedation_2009__2_[1].pdf. 2009.
  12. Organización Médica Colegial (OMC) and Sociedad Española de Cuidados Paliativos. (SECPAL), Guía de Sedación Paliativa, in https://www.cgcom.es/sites/default/files/guia_sedacci. 2012.
  13. Dean MM, Cellarius V, Henry B, Oneschuk D, Librach Canadian Society Of Palliative Care Physicians Taskforce SL. Framework for continuous palliative sedation therapy in Canada. J Palliat Med. 2012 Aug;15(8):870–9. 10.1089/jpm.2011.0498 DOI: https://doi.org/10.1089/jpm.2011.0498
  14. Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med. 2005 Aug;8(4):716–29. 10.1089/jpm.2005.8.716 DOI: https://doi.org/10.1089/jpm.2005.8.716
  15. Kremling A, Schildmann J. What do you mean by “palliative sedation”?: pre-explicative analyses as preliminary steps towards better definitions. BMC Palliat Care. 2020 Sep;19(1):147. 10.1186/s12904-020-00635-9 DOI: https://doi.org/10.1186/s12904-020-00635-9
  16. Kremling A, Bausewein C, Klein C, Schildmann E, Ostgathe C, Ziegler K, et al. Intentional Sedation as a Means to Ease Suffering: A Systematically Constructed Terminology for Sedation in Palliative Care. J Palliat Med. 2022 May;25(5):793–6. 10.1089/jpm.2021.0428 DOI: https://doi.org/10.1089/jpm.2021.0428
  17. Stiel S, Nurnus M, Ostgathe C, Klein C. Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services. BMC Palliat Care. 2018 Mar;17(1):48. 10.1186/s12904-018-0303-7 DOI: https://doi.org/10.1186/s12904-018-0303-7
  18. Morita T, Tei Y, Inoue S. Ethical validity of palliative sedation therapy. J Pain Symptom Manage. 2003 Feb;25(2):103–5. 10.1016/S0885-3924(02)00635-8 DOI: https://doi.org/10.1016/S0885-3924(02)00635-8
  19. Rousseau P. The ethics of palliative sedation. Caring. 2004 Nov;23(11):14–9.
  20. Miccinesi G, Rietjens JA, Deliens L, Paci E, Bosshard G, Nilstun T, et al.; EURELD Consortium. Continuous deep sedation: physicians’ experiences in six European countries. J Pain Symptom Manage. 2006 Feb;31(2):122–9. 10.1016/j.jpainsymman.2005.07.004 DOI: https://doi.org/10.1016/j.jpainsymman.2005.07.004
  21. Heijltjes MT, van Thiel GJ, Rietjens JA, van der Heide A, de Graeff A, van Delden JJ. Changing Practices in the Use of Continuous Sedation at the End of Life: A Systematic Review of the Literature. J Pain Symptom Manage. 2020 Oct;60(4):828–846.e3. 10.1016/j.jpainsymman.2020.06.019 DOI: https://doi.org/10.1016/j.jpainsymman.2020.06.019
  22. Bosshard G, Zellweger U, Bopp M, Schmid M, Hurst SA, Puhan MA, et al. Medical End-of-Life Practices in Switzerland: A Comparison of 2001 and 2013. JAMA Intern Med. 2016 Apr;176(4):555–6. 10.1001/jamainternmed.2015.7676 DOI: https://doi.org/10.1001/jamainternmed.2015.7676
  23. Hurst SA, Zellweger U, Bosshard G, Bopp M; Swiss Medical End-of-Life Decisions Study Group. Medical end-of-life practices in Swiss cultural regions: a death certificate study. BMC Med. 2018 Apr;16(1):54. 10.1186/s12916-018-1043-5 DOI: https://doi.org/10.1186/s12916-018-1043-5
  24. Ziegler S, Schmid M, Bopp M, Bosshard G, Puhan MA. Continuous deep sedation until death in patients admitted to palliative care specialists and internists: a focus group study on conceptual understanding and administration in German-speaking Switzerland. Swiss Med Wkly. 2018 Aug;148:w14657. 10.4414/smw.2018.14657 DOI: https://doi.org/10.4414/smw.2018.14657
  25. Levy MH, Cohen SD. Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol. 2005 Apr;32(2):237–46. 10.1053/j.seminoncol.2005.02.003 DOI: https://doi.org/10.1053/j.seminoncol.2005.02.003
  26. Hasselaar JG, Reuzel RP, van den Muijsenbergh ME, Koopmans RT, Leget CJ, Crul BJ, et al. Dealing with delicate issues in continuous deep sedation. Varying practices among Dutch medical specialists, general practitioners, and nursing home physicians. Arch Intern Med. 2008 Mar;168(5):537–43. 10.1001/archinternmed.2007.130 DOI: https://doi.org/10.1001/archinternmed.2007.130
  27. palliative ch, Bigorio 2005, Recommandations "Sédation palliative", Consensus sur la meilleure pratique en soins palliatifs en Suisse., in https://www.palliative.ch/public/dokumente/was_wir_tun/angebote/bigorio_best_practice/BIGORIO_2005_-_Recommandations_Sedation_palliative.pdf. 2005: palliative.ch.
  28. Beller EM, van Driel ML, McGregor L, Truong S, Mitchell G. Palliative pharmacological sedation for terminally ill adults. Cochrane Database Syst Rev. 2015 Jan;1(1):CD010206. 10.1002/14651858.CD010206.pub2 DOI: https://doi.org/10.1002/14651858.CD010206.pub2
  29. Belar A, Arantzamendi M, Menten J, Payne S, Hasselaar J, Centeno C. The Decision-Making Process for Palliative Sedation for Patients with Advanced Cancer-Analysis from a Systematic Review of Prospective Studies. Cancers (Basel). 2022 Jan;14(2):301. 10.3390/cancers14020301 DOI: https://doi.org/10.3390/cancers14020301
  30. Robijn L, Chambaere K, Raus K, Rietjens J, Deliens L. Reasons for continuous sedation until death in cancer patients: a qualitative interview study. Eur J Cancer Care (Engl). 2017 Jan;26(1):e12405. 10.1111/ecc.12405 DOI: https://doi.org/10.1111/ecc.12405
  31. Verkerk M, van Wijlick E, Legemaate J, de Graeff A. A national guideline for palliative sedation in the Netherlands. J Pain Symptom Manage. 2007 Dec;34(6):666–70. 10.1016/j.jpainsymman.2007.01.005 DOI: https://doi.org/10.1016/j.jpainsymman.2007.01.005
  32. The Italian Association for Palliative Care (SICP). Raccomandazioni della SICP sulla Sedazione Terminale/Sedazione Palliativa., in https://www.fondazioneluvi.org/wpcontent/uploads/2017/01/Sedazione-Terminale-Sedazione-Palliativa.pdf. 2012.
  33. Joan Santamaria Semis GS, Rosselló Forteza C, et al. 2013., Guía de sedación paliativa: Recomendaciones para los profesionales de la salud de las Islas Baleares, in www.caib.es/sacmicrofront/archivopub.do?ctrl=MCRST3145ZI147433&id=147433. 2013.
  34. Académie Suisse des Sciences Médicales (ASSM). La capacité de discernement dans la pratique médicale, in https://www.samw.ch/fr/Publications/Directives.html. 2019.
  35. Gélinas C, Fillion L, Puntillo KA, Viens C, Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care. 2006 Jul;15(4):420–7. 10.4037/ajcc2006.15.4.420 DOI: https://doi.org/10.4037/ajcc2006.15.4.420
  36. Rat P, Jouve E, Pickering G, Donnarel L, Nguyen L, Michel M, et al. Validation of an acute pain-behavior scale for older persons with inability to communicate verbally: algoplus. Eur J Pain. 2011 Feb;15(2):198.e1–10. DOI: https://doi.org/10.1016/j.ejpain.2010.06.012
  37. Campbell ML, Templin T, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med. 2010 Mar;13(3):285–90. 10.1089/jpm.2009.0229 DOI: https://doi.org/10.1089/jpm.2009.0229
  38. Bush SH, Grassau PA, Yarmo MN, Zhang T, Zinkie SJ, Pereira JL. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice. BMC Palliat Care. 2014 Mar;13(1):17. 10.1186/1472-684X-13-17 DOI: https://doi.org/10.1186/1472-684X-13-17
  39. Crawford GB, Dzierżanowski T, Hauser K, Larkin P, Luque-Blanco AI, Murphy I, et al.; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines. ESMO Open. 2021 Aug;6(4):100225. 10.1016/j.esmoop.2021.100225 DOI: https://doi.org/10.1016/j.esmoop.2021.100225
  40. Mupamombe CT, Luczkiewicz D, Kerr C. Dexmedetomidine as an Option for Opioid Refractory Pain in the Hospice Setting. J Palliat Med. 2019 Nov;22(11):1478–81. 10.1089/jpm.2019.0035 DOI: https://doi.org/10.1089/jpm.2019.0035
  41. Hofherr ML, Abrahm JL, Rickerson E. Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life. J Palliat Med. 2020 Nov;23(11):1515–7. 10.1089/jpm.2019.0427 DOI: https://doi.org/10.1089/jpm.2019.0427
  42. Thomas B, Lo WA, Nangati Z, Barclay G. Dexmedetomidine for hyperactive delirium at the end of life: an open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit. Palliat Med. 2021 Apr;35(4):729–37. 10.1177/0269216321994440 DOI: https://doi.org/10.1177/0269216321994440
  43. Roberts SB, Wozencraft CP, Coyne PJ, Smith TJ. Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. J Palliat Med. 2011 Mar;14(3):371–3. 10.1089/jpm.2010.0235 DOI: https://doi.org/10.1089/jpm.2010.0235
  44. Gaertner J, Fusi-Schmidhauser T. Dexmedetomidine: a magic bullet on its way into palliative care-a narrative review and practice recommendations. Ann Palliat Med. 2022 Apr;11(4):1491–504. 10.21037/apm-21-1989 DOI: https://doi.org/10.21037/apm-21-1989
  45. McWilliams K, Keeley PW, Waterhouse ET. Propofol for terminal sedation in palliative care: a systematic review. J Palliat Med. 2010 Jan;13(1):73–6. 10.1089/jpm.2009.0126 DOI: https://doi.org/10.1089/jpm.2009.0126
  46. Sulistio M, Wojnar R, Michael NG. Propofol for palliative sedation. BMJ Support Palliat Care. 2020 Mar;10(1):4–6. 10.1136/bmjspcare-2019-001899 DOI: https://doi.org/10.1136/bmjspcare-2019-001899
  47. Clark D. ‘Total pain’, disciplinary power and the body in the work of Cicely Saunders, 1958-1967. Soc Sci Med. 1999 Sep;49(6):727–36. 10.1016/S0277-9536(99)00098-2 DOI: https://doi.org/10.1016/S0277-9536(99)00098-2
  48. Grech A, Marks A. Existential Suffering Part 1: definition and Diagnosis #319. J Palliat Med. 2017 Jan;20(1):93–4. 10.1089/jpm.2016.0422 DOI: https://doi.org/10.1089/jpm.2016.0422
  49. Boston P, Bruce A, Schreiber R. Existential suffering in the palliative care setting: an integrated literature review. J Pain Symptom Manage. 2011 Mar;41(3):604–18. 10.1016/j.jpainsymman.2010.05.010 DOI: https://doi.org/10.1016/j.jpainsymman.2010.05.010
  50. Rodrigues P, Crokaert J, Gastmans C. Palliative Sedation for Existential Suffering: A Systematic Review of Argument-Based Ethics Literature. J Pain Symptom Manage. 2018 Jun;55(6):1577–90. 10.1016/j.jpainsymman.2018.01.013 DOI: https://doi.org/10.1016/j.jpainsymman.2018.01.013
  51. Twycross R. Reflections on palliative sedation. Palliat Care. 2019 Jan;12:1178224218823511. 10.1177/1178224218823511 DOI: https://doi.org/10.1177/1178224218823511
  52. Imai K, Morita T, Akechi T, Baba M, Yamaguchi T, Sumi H, et al. The Principles of Revised Clinical Guidelines about Palliative Sedation Therapy of the Japanese Society for Palliative Medicine. J Palliat Med. 2020 Sep;23(9):1184–90. 10.1089/jpm.2019.0626 DOI: https://doi.org/10.1089/jpm.2019.0626
  53. Ostgathe C. Einsatz sedierender Medikamente in der Spezialisierten Palliativversorgung, in https://www.dgpalliativmedizin.de/images/210422_Broschu%CC%88re_SedPall_Gesamt.pdf. 2021.
  54. Song HN, Lee US, Lee GW, Hwang IG, Kang JH, Eduardo B. Long-Term Intermittent Palliative Sedation for Refractory Symptoms at the End of Life in Two Cancer Patients. J Palliat Med. 2015 Sep;18(9):807–10. 10.1089/jpm.2014.0357 DOI: https://doi.org/10.1089/jpm.2014.0357
  55. Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, et al. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012 Apr;30(12):1378–83. 10.1200/JCO.2011.37.3795 DOI: https://doi.org/10.1200/JCO.2011.37.3795
  56. Claessens P, Menten J, Schotsmans P, Broeckaert B. Palliative sedation: a review of the research literature. J Pain Symptom Manage. 2008 Sep;36(3):310–33. 10.1016/j.jpainsymman.2007.10.004 DOI: https://doi.org/10.1016/j.jpainsymman.2007.10.004
  57. Barathi B, Chandra PS. Palliative Sedation in Advanced Cancer Patients: Does it Shorten Survival Time? - A Systematic Review. Indian J Palliat Care. 2013 Jan;19(1):40–7. 10.4103/0973-1075.110236 DOI: https://doi.org/10.4103/0973-1075.110236
  58. Kirk TW, Mahon MM; Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010 May;39(5):914–23. 10.1016/j.jpainsymman.2010.01.009 DOI: https://doi.org/10.1016/j.jpainsymman.2010.01.009
  59. Uchida M, Morita T, Akechi T, Yokomichi N, Sakashita A, Hisanaga T, et al.; Phase-R Delirium Study Group. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients? Psychooncology. 2020 Nov;29(11):1842–9. 10.1002/pon.5499 DOI: https://doi.org/10.1002/pon.5499
  60. Gaertner J, Eychmueller S, Leyhe T, Bueche D, Savaskan E, Schlögl M. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?-a critical appraisal of recent randomized controlled trials. Ann Palliat Med. 2019 Sep;8(4):504–15. 10.21037/apm.2019.03.06 DOI: https://doi.org/10.21037/apm.2019.03.06
  61. Vieille M, Dany L, Coz PL, Avon S, Keraval C, Salas S, et al. Perception, Beliefs, and Attitudes Regarding Sedation Practices among Palliative Care Nurses and Physicians: A Qualitative Study. Palliat Med Rep. 2021 May;2(1):160–7. 10.1089/pmr.2021.0022 DOI: https://doi.org/10.1089/pmr.2021.0022

Most read articles by the same author(s)